Literature DB >> 20003092

Prevalence and predictors of recurrence of major depressive disorder in the adult population.

F Hardeveld1, J Spijker, R De Graaf, W A Nolen, A T F Beekman.   

Abstract

OBJECTIVE: Knowledge of the risk of recurrence after recovery of a major depressive disorder (MDD) is of clinical and scientific importance. The purpose of this paper was to provide a systematic review of the prevalence and predictors of recurrence of MDD.
METHOD: Studies were searched in Medline en PsychINFO using the search terms 'recur*', 'relaps*', 'depress*', 'predict*' and course.
RESULTS: Recurrence of MDD in specialised mental healthcare settings is high (60% after 5 years, 67% after 10 years and 85% after 15 years) and seems lower in the general population (35% after 15 years). Number of previous episodes and subclinical residual symptoms appear to be the most important predictors. Gender, civil status and socioeconomic status seem not related to the recurrence of MDD.
CONCLUSION: Clinical factors seem the most important predictors of recurrence. Data from studies performed in the general population and primary care on the recurrent course of MDD are scarce.

Entities:  

Mesh:

Year:  2009        PMID: 20003092     DOI: 10.1111/j.1600-0447.2009.01519.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  127 in total

1.  A proposed model for economic evaluations of major depressive disorder.

Authors:  Hossein Haji Ali Afzali; Jonathan Karnon; Jodi Gray
Journal:  Eur J Health Econ       Date:  2011-06-02

Review 2.  The costs of depression.

Authors:  Ronald C Kessler
Journal:  Psychiatr Clin North Am       Date:  2011-12-16

3.  Number of recent stressful life events and incident cardiovascular disease: Moderation by lifetime depressive disorder.

Authors:  Jessica Berntson; Jay S Patel; Jesse C Stewart
Journal:  J Psychosom Res       Date:  2017-06-12       Impact factor: 3.006

Review 4.  Depression During and After the Perimenopause: Impact of Hormones, Genetics, and Environmental Determinants of Disease.

Authors:  Joyce T Bromberger; Cynthia Neill Epperson
Journal:  Obstet Gynecol Clin North Am       Date:  2018-10-25       Impact factor: 2.844

5.  Measurement invariance of the patient health questionnaire-9 (PHQ-9) depression screener in U.S. adults across sex, race/ethnicity, and education level: NHANES 2005-2016.

Authors:  Jay S Patel; Youngha Oh; Kevin L Rand; Wei Wu; Melissa A Cyders; Kurt Kroenke; Jesse C Stewart
Journal:  Depress Anxiety       Date:  2019-07-29       Impact factor: 6.505

6.  Risk factors for relapse and recurrence of depression in adults and how they operate: A four-phase systematic review and meta-synthesis.

Authors:  J E J Buckman; A Underwood; K Clarke; R Saunders; S D Hollon; P Fearon; S Pilling
Journal:  Clin Psychol Rev       Date:  2018-07-29

7.  Presence and Predictive Value of Obsessive-Compulsive Symptoms in Anxiety and Depressive Disorders.

Authors:  Mieke Klein Hofmeijer-Sevink; Neeltje M Batelaan; Harold J G M van Megen; Marcel A van den Hout; Brenda W Penninx; Anton J L M van Balkom; Danielle C Cath
Journal:  Can J Psychiatry       Date:  2017-05-16       Impact factor: 4.356

Review 8.  Association of Microvascular Dysfunction With Late-Life Depression: A Systematic Review and Meta-analysis.

Authors:  Marnix J M van Agtmaal; Alfons J H M Houben; Frans Pouwer; Coen D A Stehouwer; Miranda T Schram
Journal:  JAMA Psychiatry       Date:  2017-07-01       Impact factor: 21.596

9.  Gender and age differences in the recurrence of sickness absence due to common mental disorders: a longitudinal study.

Authors:  Petra C Koopmans; Corné Am Roelen; Ute Bültmann; Rob Hoedeman; Jac Jl van der Klink; Johan W Groothoff
Journal:  BMC Public Health       Date:  2010-07-20       Impact factor: 3.295

10.  Does hospital admission risk for depression vary across social groups? A population-based register study of 231,629 middle-aged Finns.

Authors:  Heta Moustgaard; Kaisla Joutsenniemi; Pekka Martikainen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-05-28       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.